MIF4GD
MIF4G domain-containing protein
Also known as: AD023, MGC45027, MI4GD_HUMAN, MIFD, SLIP1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- A9UHW6
- Gene
- MIF4GD
- Ensembl
- ENSG00000125457
- Chromosome
- 17
- Canonical length
- 222 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoli,Golgi apparatus,Cytosol
OverviewNCBI Gene
This gene encodes a protein which interacts with the N-terminus of the stem-loop binding protein (SLBP) and the 3' end of histone mRNA. This interaction facilitates the activation of histone mRNA translation. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jun 2011]
Canonical amino-acid sequenceUniProt
222 residues, UniProt reviewed canonical sequence.
>A9UHW6|MIF4GD
1 MGEPSREEYK IQSFDAETQQ LLKTALKDPG AVDLEKVANV IVDHSLQDCV FSKEAGRMCY
61 AIIQAESKQA GQSVFRRGLL NRLQQEYQAR EQLRARSLQG WVCYVTFICN IFDYLRVNNM
121 PMMALVNPVY DCLFRLAQPD SLSKEEEVDC LVLQLHRVGE QLEKMNGQRM DELFVLIRDG
181 FLLPTGLSSL AQLLLLEIIE FRAAGWKTTP AAHKYYYSEV SDLocalizationUniProt · AlphaFold · HPA
Whether an antibody against MIF4GD can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.27
- Highest tissue expression
- 55 nTPM
Expression across tissuesHPA
Tissue
- skeletal muscle: 55 nTPM
- bone marrow: 41 nTPM
- blood vessel: 41 nTPM
- lymph node: 31 nTPM
- spleen: 28 nTPM
- skin: 28 nTPM
Single-cell type
- megakaryocytes: 136 nCPM
- platelets: 130 nCPM
- pdcs: 91 nCPM
- esophageal apical cells: 83 nCPM
- esophageal suprabasal cells: 72 nCPM
- cdc: 56 nCPM
Immune cell
- plasmacytoid DC: 227 nTPM
- myeloid DC: 92 nTPM
- classical monocyte: 78 nTPM
- T-reg: 69 nTPM
- total PBMC: 60 nTPM
- MAIT T-cell: 57 nTPM
Brain region
- white matter: 18 nTPM
- medulla oblongata: 18 nTPM
- basal ganglia: 16 nTPM
- spinal cord: 16 nTPM
- midbrain: 15 nTPM
- cerebellum: 14 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.5
- gnomAD pLI
- 0
- gnomAD missense Z
- 0.63
- DepMap mean gene effect
- -0.22
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of MIF4GD in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads MIF4GD as an antibody target. Whether an autoantibody or antibody against MIF4GD could matter depends on whether native MIF4GD is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
MIF4GD is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label MIF4GD as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...